Biosimilars: Company Strategies to Capture Value from the Biologics Market.
- Published in:
- Pharmaceuticals (14248247), 2012, v. 5, n. 12, p. 1393, doi. 10.3390/ph5121393
- By:
- Publication type:
- Article
Works matching IS 14248247 AND DT 2012 AND VI 5 AND IP 12
Results: 7
1
2
The Liver as a Target Organ for Gene Therapy: State of the Art, Challenges, and Future Perspectives.
- Published in:
- Pharmaceuticals (14248247), 2012, v. 5, n. 12, p. 1372, doi. 10.3390/ph5121372
- By:
- Publication type:
- Article
3
Mechanistic and Pharmacological Issues of Aspirin as an Anticancer Agent.
- Published in:
- Pharmaceuticals (14248247), 2012, v. 5, n. 12, p. 1346, doi. 10.3390/ph5121346
- By:
- Publication type:
- Article
4
Integration of Ligand-Based Drug Screening with Structure-Based Drug Screening by Combining Maximum Volume Overlapping Score with Ligand Docking.
- Published in:
- Pharmaceuticals (14248247), 2012, v. 5, n. 12, p. 1332, doi. 10.3390/ph5121332
- By:
- Publication type:
- Article
5
Multiple Facets of cAMP Signalling and Physiological Impact: cAMP Compartmentalization in the Lung.
- Published in:
- Pharmaceuticals (14248247), 2012, v. 5, n. 12, p. 1291, doi. 10.3390/ph5121291
- By:
- Publication type:
- Article
6
Synthesis and COX-2 Inhibitory Activity of 4-[(E)-2-(4-Oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethenyl]benzene-1-sulfonamide and Its Analogs.
- Published in:
- Pharmaceuticals (14248247), 2012, v. 5, n. 12, p. 1282, doi. 10.3390/ph5121282
- By:
- Publication type:
- Article
7
Cell Penetrating Peptoids (CPPos): Synthesis of a Small Combinatorial Library by Using IRORI MiniKans.
- Published in:
- Pharmaceuticals (14248247), 2012, v. 5, n. 12, p. 1265, doi. 10.3390/ph5121265
- By:
- Publication type:
- Article